United Therapeutics (NASDAQ: UTHR) net income
United Therapeutics reported a net profit of $1,335m for fiscal 2025, 11.7% more than in fiscal 2024 ($1,195m). Its net margin was 41.9%. Earnings per share were $30.13.
United Therapeutics has grown its net income for 4 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. The biggest drop was in fiscal 2017, −41.4%. It reported a loss in 1 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $1,335m | +11.7% | 41.9% | $30.13 |
| 2024 | $1,195m | +21.4% | 41.5% | $26.44 |
| 2023 | $984.8m | +35.4% | 42.3% | $21.04 |
| 2022 | $727.3m | +52.9% | 37.6% | $15.98 |
| 2021 | $475.8m | −7.6% | 28.2% | $10.60 |
| 2020 | $514.8m | — | 34.7% | $11.65 |
| 2019 | −$104.5m | −117.7% | −7.2% | −$2.39 |
| 2018 | $589.2m | +41.0% | 36.2% | $13.54 |
| 2017 | $417.9m | −41.4% | 24.2% | $9.50 |
| 2016 | $713.7m | — | 44.6% | $16.29 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
United Therapeutics net income compared with its sector
By net income for its latest fiscal year, United Therapeutics ranks 35th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of United Therapeutics, 41.9%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 33rd | TEVA Pharmaceutical Industries | $1,410m | 8.2% |
| 34th | IQVIA | $1,360m | 8.3% |
| 35th | United Therapeutics | $1,335m | 41.9% |
| 36th | Agilent Technologies | $1,303m | 18.8% |
| 37th | Biogen | $1,293m | 13.1% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of United Therapeutics
- How much did United Therapeutics earn in fiscal 2025?
- United Therapeutics reported a net profit of $1,335m for fiscal 2025. In fiscal 2024 it reported a net profit of $1,195m.
- What are the earnings per share of United Therapeutics?
- They were $30.13 in fiscal 2025, compared with $26.44 in fiscal 2024.
- What is the net margin of United Therapeutics?
- In fiscal 2025 its net profit was 41.9% of its revenue.
- What was the most profitable year for United Therapeutics?
- Of its last 10 fiscal years, fiscal 2025, with $1,335m.
- Where does United Therapeutics rank in its sector by net income?
- It ranks 35th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for United Therapeutics come from?
- From the annual report (Form 10-K) that United Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that United Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on United Therapeutics: the United Therapeutics page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.